Spyre Therapeutics (SYRE) Amortizatization of Intangibles (2016 - 2026)
Spyre Therapeutics' Amortizatization of Intangibles history spans 11 years, with the latest figure at $2.1 million for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles rose 123.21% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $8.1 million, changed N/A, while the annual FY2025 figure was $8.1 million, N/A changed from the prior year.
- Amortizatization of Intangibles reached $2.1 million in Q4 2025 per SYRE's latest filing, up from $1.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.6 million in Q2 2024 to a low of -$9.0 million in Q4 2024.
- Average Amortizatization of Intangibles over 5 years is $407950.0, with a median of $158000.0 recorded in 2022.
- The largest YoY upside for Amortizatization of Intangibles was 8785.37% in 2024 against a maximum downside of 2192.09% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$58000.0 in 2021, then surged by 482.76% to $222000.0 in 2022, then tumbled by 276.58% to -$392000.0 in 2023, then plummeted by 2192.09% to -$9.0 million in 2024, then skyrocketed by 123.21% to $2.1 million in 2025.
- Per Business Quant, the three most recent readings for SYRE's Amortizatization of Intangibles are $2.1 million (Q4 2025), $1.3 million (Q3 2025), and $2.0 million (Q2 2025).